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Abstract
Background: A number of health benefits including improvements in acid/base balance, bone metabolism, and
cardiovascular risk factors have been attributed to the intake of magnesium rich alkaline mineral water. This study
was designed to investigate the effects of the regular consumption of magnesium bicarbonate supplemented
spring water on pH, biochemical parameters of bone metabolism, lipid profile and blood pressure in
postmenopausal women.
Findings: In this double-blind, placebo-controlled, parallel-group, study, 67 postmenopausal women were
randomised to receive between 1500 mL and 1800 mL daily of magnesium bicarbonate supplemented spring
water (650 mg/L bicarbonate, 120 mg/L magnesium, pH 8.3-8.5) (supplemented water group) or spring water
without supplements (control water group) over 84 days. Over this period biomarkers of bone turnover (serum
parathyroid hormone (PTH), 1,25-dihydroxyvitamin D, osteocalcin, urinary telopeptides and hydroxyproline), serum
lipids (total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides), venous and urinary pH were measured
together with measurements of standard biochemistry, haematology and urine examinations.
Serum magnesium concentrations and urinary pH in subjects consuming the magnesium bicarbonate supplemen-
ted water increased significantly at Day 84 compared to subjects consuming the spring water control (magnesium
- p = 0.03; pH - p = 0.018). The consumption of spring water led to a trend for an increase in parathyroid hor-
mone (PTH) concentrations while the PTH concentrations remained stable with the intake of the supplemented
spring water. However there were no significant effects of magnesium bicarbonate supplementation in changes to
biomarkers of bone mineral metabolism (n-telopeptides, hydroxyproline, osteocalcin and 1,25-dihydroxyvitamin D)
or serum lipids or blood pressure in postmenopausal women from Day 0 to Day 84.
Conclusions: Short term regular ingestion of magnesium bicarbonate supplemented water provides a source of
orally available magnesium. Long term clinical studies are required to investigate any health benefits.
Trial registration: ACTRN12609000863235
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Epidemiological observational studies have found an
inverse association between the incidence of, and mortal-
ity from, cardiovascular disease and increased drinking of
water containing mineral salts of calcium and magnesium
[1-3]; particularly in women [4]. In case control studies,
drinking water with greater than 8 mg/L of magnesium
was associated with lower risk of death from myocardial
infarction [4-6]. A recent meta-analysis of such epide-
miology studies further supported the inverse association
between magnesium levels in drinking water and cardio-
vascular mortality [7]. A lower risk of myocardial infarc-
tion among men drinking water with magnesium and
bicarbonate with concentrations of greater than 110 mg/
L compared to those who consumed magnesium in water
with minimal bicarbonate was imputed from epidemiolo-
gical studies in Sweden [6,8]. It is possible, therefore, that
any beneficial effects from the magnesium content of
waters may be enhanced by bicarbonate.
Clinical studies have reported that bicarbonate from
mineral waters lowers bone resorption [reviewed in [9]]
and may reduce cardiovascular risk as evidenced by asso-
ciated decreases in early markers of atherosclerosis in
healthy postmenopausal women [10]. Western diets gener-
ally have a high dietary acid load and are associated with
in a low intake of minerals such as magnesium, calcium
and potassium. Such diets can induce a chronic, low-level,
metabolic acidosis [11-13]. The degree of acidosis also
increases with age and, therefore, it has been postulated
that acidosis may be associated with some of the diseases
of aging [12]. Drinking water containing bicarbonate may
represent a means of regulating acid base balance.
Magnesium is a cofactor for approximately 300
enzymes. About 50% of magnesium in the body resides
in bone where it is directly involved in calcium and bone
homeostasis. Magnesium affects the function of the para-
thyroid glands [14] where it acts as an agonist at the cal-
cium-sensing receptors and, like calcium, can decrease
parathyroid hormone (PTH) secretion [15]. Low magne-
sium status has been associated with cardiovascular dis-
ease, hypertension, diabetes [16] and osteoporosis [17].
Magnesium supplementation has been linked with sup-
pression of bone turnover [18] and improvements in lipid
profile and blood pressure [19,20].
This randomised double-blind, placebo-controlled
study was conducted in postmenopausal women to
investigate whether the short term regular ingestion of
spring water supplemented with magnesium bicarbonate
could contribute to the intake of magnesium and influ-
ence acid base balance, metabolic parameters of bone
turnover and cardiovascular risk factors (blood pressure
and serum lipids).
Methods
A randomised, double-blind, placebo-controlled, paral-
lel-arm study comparing the daily intake of 1500 mL -
1800 mL of magnesium bicarbonate supplemented
spring water with non supplemented spring water (pla-
cebo) was undertaken in postmenopausal women, while
on their usual diet, over an 84 day period. The study
was conducted from 31 August 2005 to 3 November
2006 and approved by the St Vincent’s Hospital Human
Research Ethics Committee.
Subjects
Ninety-one subjects attended the Clinical Trials Centre
for screening for eligibility. All screened subjects pro-
vided written informed consent to participate in the
study prior to commencement of screening procedures.
Only postmenopausal subjects aged 50 -70 years and
with a body mass index (BMI) 20-35 kg/m
2were eligi-
ble. Subjects were excluded if physical and mental
health status, including laboratory abnormalities, indi-
cated serious or chronic illness (abnormal liver function
tests (LFTs) or electrolytes, creatinine clearance < 60
mL/min, haemoglobin < 10 g/L), if they were intolerant
to magnesium-containing products, taking certain medi-
cations (antacids other than proton pump inhibitors or
H 2agonists, diuretics, calcium or magnesium supple-
ments) or planned medication changes. Subjects using
hormone replacement therapy (HRT) were to have been
on a stable dose for at least one month prior to screen-
ing and continue this dose through the study. Subjects
on special diets (including vegan, weight loss or high
protein), those with a history of frequent use of magne-
sium based laxatives and substance abuse (including
nicotine) were excluded.
Protocol - treatment
Of the 91 screened, 23 failed to satisfy the entry criteria
and one was excluded due to poor venous access. The
remaining 67 postmenopausal women were randomised
in a 1:1 ratio to receive between 1500 mL and 1800 mL
daily of magnesium bicarbonate supplemented spring
water (650 mg/L bicarbonate, 120 mg/L magnesium, pH
8.3-8.5) (supplemented water group) or spring water
without supplements (control water group) over three
months (84 days). For those consuming the supplemen-
ted water, this volume resulted in a daily dose of 975 -
1170 mg bicarbonate and 180 - 216 mg of magnesium.
There was no bicarbonate and negligible amounts of
magnesium (< 5 mg/L) in the spring water given to the
control group. Analysis of the spring water (control)
was conducted by National Association of Testing
Authorities (NATA) accredited (#1884) SONIC
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are listed in Additional file 1.
The water was supplied in 600 mL identical bottles so
that subjects were blinded to the type of water they
received. Subjects were at liberty to choose the time at
which they consumed the water and were discouraged
from drinking the study product with meals. The water
could be chilled but not heated to be used in beverages
such as tea or coffee, or for cooking. All study water
consumed was recorded by subjects in the drink diary
and bottle caps returned at each study visit to evaluate
compliance, where 100% compliance was defined as
daily consumption of between 1500 mL and 1800 mL of
water. Subjects were requested to maintain consistency
of nutritional habits and lifestyle behaviours throughout
the study period.
Measurements
Subjects were seen at Baseline and at Days 14, 42 and
84. Any changes in diet were noted. Blood and urine
samples were collected at every visit to measure markers
of bone turnover (PTH, 1,25-dihydroxyvitamin D and
osteocalcin, urinary telopeptides, hydroxyproline) and
pH. Serum fasting lipids (total cholesterol, HDL, LDL,
triglycerides), serum biochemistry (albumin, alkaline
phosphatase, alanine amino transferase [ALT], aspartate
amino transferase [AST], bicarbonate, total bilirubin,
chloride, calcium, creatine kinase, creatinine, fasting glu-
cose, lactate dehydrogenase [LDH], magnesium, potas-
sium, sodium, total protein, urea and uric acid) and
haematology were measured at each visit. Urine was col-
lected for 24 h for the measurement of calcium, phos-
phate, creatinine and free cortisol concentrations and
excretion. Physical examinations were performed;
including blood pressure (supine and standing); body
weight recorded and adverse event reports were elicited
at each visit.
All biochemical, haematology and urinalysis testing
was performed by NATA accredited (#2115) Institute of
Laboratory Medicine (SydPath) St Vincent’s Hospital
NSW.
Statistics
The change from Baseline (Day 0) to each study visit at
Days 14, 42 and 84 was compared between treatment
groups for all biochemical, blood lipid, blood pressure,
pH measures, haematological, urinalysis and bone turn-
over markers. Tables and figures present the mean and
standard deviation (SD) for each parameter at baseline
and at each visit. Continuous measures were compared
across treatments using independent, two-sample,
unpaired t-tests if the data were normally distributed,
otherwise the Wilcoxon Rank Sum Test was used. Cate-
gorical measures were compared using Chi square or
Fisher’s Exact test. No adjustments were made for mul-
tiple testing as this was an exploratory study and it is
acknowledged that there is an increased risk of making
Type I errors given the number of tests performed.
Repeated measures analyses of variance were per-
formed for all outcome variables, incorporating all visits
from baseline to Day 14, Day 42 and Day 84 together
with treatment group as factors in the analysis. If the
p-value for the change in the variable was less than or
equal to 0.10 then a generalised linear mixed model
with a random intercept term (for subject) was fitted.
The outcome in the model was the measure of interest
at Days 0, 14, 42 and 84 and the model included the
main effects of group and visit. The p-value from the
test of the interaction between group and time was the
result of interest and p < 0.05 was considered statisti-
cally significant.
Results
Sixty-seven eligible subjects received at least one dose of
magnesium bicarbonate supplemented spring water
{supplemented water group; n = 34} or one dose of
spring water without supplement {control group; n =
33}, had a valid baseline measurement and returned for
at least one post-baseline visit. All analyses were carried
out on this population which was identical to the safety
population.
Mean (SD) age was 57 (4.4) years and 59 (5.5) years in
the control and supplemented water groups, respec-
tively. Body weight and BMI remained unchanged in
both groups (Table 1) over the study period. Dietary
habits in both groups were unchanged as assessed at
each visit.
There were no significant group differences in all
parameters measured at baseline (Day 0) (Tables 2, 3, 4,
5, Additional files 2, 3, 4, 5).
The most common pre-existing conditions in both
groups were self-reported drug hypersensitivity, osteoar-
thritis and lipid disorders for which subjects used hypo-
lipidaemics, anti-inflammatory and antirheumatic
products and analgesics. The compliance rate was high
in both groups {28 (84.8%) in the control and 29
(85.3%) and supplemented water groups} according to
daily diary records. The 1500 mL -1800 mL of water
volume was well tolerated by all subjects.
Outcome Analyses
There were no statistically significant differences in
change between the supplemented water group and the
water control group from baseline to Day 14, 42 and 84
in any of the measures of bone mineral turnover (n-telo-
peptides, hydroxyproline, osteocalcin and 1,25-
dihydroxyvitamin D) (Table 2, Additional file 2) or in
cardiovascular parameters of serum lipid profile
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(Table 3, Additional file 3) and blood pressure (Table 4,
Additional file 4). Measurements of bicarbonate, cal-
cium, creatinine, sodium (Table 5, Additional file 5) and
most serum biochemistry also did not show significant
differences between the two groups remaining within
normal ranges (data not shown). Haematology para-
meters remained unaltered through study period for
both water groups (data not shown).
The concentration of serum PTH increased from Day
0 (3.85 pmol/L) to Day 84 (4.57 pmol/L) with control
water consumption compared to supplemented water
for which the concentration remained relatively constant
(4.24 and 4.21 pmol/L, respectively). There was a trend
towards a difference in the change in PTH concentra-
tion between the two groups from Day 0 to Day 84
(0.74 pmol/L; 95% Confidence Interval (CI): -0.03 to
1.52 pmol; p = 0.059) (Figure 1, Table 2). There was no
significant difference in the change in PTH concentra-
tion between the two groups at Day 0 to Day 14 or Day
42 (see Additional file 2).
The serum concentration of magnesium increased
with the intake of the supplemented water compared to
that of control water intake {0.022 mmol/L (95% CI:
0.003 to 0.041 mmol/L)} (Table 5, Additional file 5).
The difference between the two groups in the change
Table 1 Body weight and BMI at all visits for spring water and magnesium bicarbonate (supplemented) spring water
groups
Spring Water (n = 33) Supplemented Spring Water (n = 34)
Visit Day 0 Day 14 Day 42 Day 84 Day 0 Day 14 Day 42 Day 84
Weight
(kg)
Mean (SD) 67.99
(11.58)
68.09
(11.76)
68.11
(12.03)
67.86
(11.54)
64.22
(8.15)
64.24
(8.32)
64.10
(8.20)
64.07
(8.61)
Change from baseline (Day 0)
(SD)
0.02 (1.01) 0.03 (1.40) -0.21 (1.98) 0.02 (0.78) -0.12 (1.36) -0.15 (1.66)
*P value 0.126 0.921 0.749 0.946
BMI (kg/
m2)
Mean (SD) 25.05 (3.64) 25.11 (3.71) 25.11 (3.78) 25.02 (3.59) 24.16
(3.14)
24.17
(3.18)
24.12
(3.13)
24.16
(3.14)
Change from baseline (Day 0)
(SD)
0.010 (0.38) 0.009 (0.54) -0.073
(0.76)
0.006
(0.29)
-0.048
(0.51)
-0.052
(0.62)
*P value 0.289 0.991 0.681 0.930
*p-value (t-test) comparing groups at Day 0 (italics) and for change from Baseline to Day 14, Day 42 and Day 84
Table 2 Serum bone metabolic markers over the study period for spring water and magnesium bicarbonate
(supplemented) spring water groups
Spring Water (n = 33) Supplemented Spring Water (n = 34)
Visit Day 0 Day 84 Day 0 Day 84
Parathyroid Hormone (pmol/L) Mean (SD) 3.85 (1.79) 4.57 (2.14) 4.24 (1.74) 4.21 (1.96)
Change from baseline (Day 0) (SD) 0.72 (1.52) -0.02 (1.65)
*P value 0.369 0.059
1,25dihydroxyvitamin D (pmol/L) Mean (SD) 120.8 (40.9) 126.8 (40.4) 118.7 (39.8) 124.3 (40.7)
Change from baseline (Day 0) (SD) 7.1 (49.1) 5.6 (47.9)
*P value 0.835 0.766
Osteocalcin Mean (SD) 13.73 (5.44) 14.42 (5.88) 15.23 (3.89) 13.79 (3.48)
(μg/L) Change from baseline (Day 0) (SD) 0.70 (4.00) 0.07 (4.00) -1.31 (3.89)
*P value 0.207 0.104
N-telopeptide excretion Mean (SD) 36.7 (21.7) 40.1 (21.3) 34.1 (17.8) 35.1 (15.7)
nmol/mM Cr) Change from baseline (Day 0) (SD) 3.4 (12.66) 1.0 (15.97)
*P value 0.588 0.440
OH proline excretion (nmol/mM Cr) Mean (SD) 15.5 (5.39) 17.2 (6.75) 15.5 (4.98) 15.6 (4.57)
Change from baseline (Day 0) (SD) 1.6 (5.98) 0.1 (4.70)
*P value 0.971 0.216
*p-value comparing groups at Day 0 (italics) and for change from Day 0 to Day 84
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magnesium was statistically significant (p = 0.027)
(Figure 2, Table 5). When data from all time points
were analysed using a repeated measures analysis of var-
iance the difference between groups in the serum con-
centrations of magnesium remained statistically
significant (p = 0.015). Serum potassium was also
increased by Day 84 with the intake of supplemented
water (p = 0.054) (Additional File 5).
Consumption of the supplemented water also signifi-
cantly increased the urinary pH at 84 days (p = 0.0182)
(Figure 3, Table 4). The venous pH remained unaltered
(Additional file 4) over the study period. There were no
other statistically significant differences in change from
Day 0 to Day 84 comparing control and supplemented
water groups in any of the other 24-hour urinary
analytes (data not shown).
Safety Evaluation
The most common adverse event considered to be
related to the water consumption was diarrhoea in five
(15.2%) and eight (23.5%) subjects in the control and
supplemented water groups, respectively. No subject suf-
fered a serious adverse event during this study.
Discussion
The present study did not show any effect of the con-
sumption of spring water supplemented with magne-
sium and bicarbonate, as part of a daily routine
including usual dietary habits, on clinically relevant
Table 3 Serum lipid profile over the study period for spring water and magnesium bicarbonate (supplemented) spring
water groups
Spring Water (n = 33) Supplemented Spring Water (n = 34)
Visit Day 0 Day 84 Day 0 Day 84
Triglyceride Mean (SD) 1.12 (0.45) 0.95 (0.39) 0.95 (0.32) 0.92 (0.46)
(mmol/L) Change from baseline (Day 0) (SD) -0.17 (0.46) -0.03 (0.39)
*P value 0.107 0.528
Cholesterol Mean (SD) 5.79 (1.6) 5.69 (1.21) 5.44 (0.78) 5.51 (0.93)
(mmol/L) Change from baseline (Day 0) (SD) -0.10 (0.63) 0.07 (0.53)
*P value 0.260 0.484
High Density Lipoprotein Mean (SD) 1.72 (0.50) 1.78 (0.47) 1.75 (0.32) 1.77 (0.32)
(mmol/L) Change from baseline (Day 0) (SD) 0.05 (0.19) 0.02 (0.19)
*P value 0.772 0.576
Low Density Lipoprotein Mean (SD) 3.57 (1.38) 3.48 (1.07) 3.31 (0.90) 3.33 (0.89)
Change from baseline (Day 0) (SD) -0.08 (0.50) 0.02 (0.38)
*P value 0.364 0.611
*p-value comparing groups at Day 0 (italics) and for change from Day 0 to Day 84
Table 4 Blood pressure (BP) and urinary pH over the study period for spring water and magnesium bicarbonate
(supplemented) spring water groups
Spring Water (n = 33) Supplemented Spring Water (n = 34)
Visit Day 0 Day 84 Day 0 Day 84
§SUPINE SYSTOLIC BP (mm Hg) Mean (SD) 119.6 (13.23) 117.4 (10.73) 121.5 (13.32) 121.9 (14.08)
Change from baseline (Day 0) (SD) -2.3 (11.64) 0.4 (10.74)
*P value 0.562 0.1606
§SUPINE DIASTOLIC BP (mm Hg) Mean (SD) 73.1 (8.88) 72.0 (6.95) 74.1 (8.47) 73.9 (8.68)
Change from baseline (Day 0) (SD) -1.2 (7.58) -0.2 (6.36)
*P value 0.650 0.367
Urinary pH Mean (SD) 6.13 (0.93) 6.17 (0.83) 6.38 (0.63) 6.66 (0.56)
Change from baseline (Day 0) (SD) 0.05 (0.86) 0.28 (0.73)
*P value 0.197 0.018
*p-value comparing groups at Day 0 (italics) and for change from Day 0 to Day 84
§ Standing systolic and diastolic BP showed no significant difference between two water groups (Data not shown)
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of 12 weeks.
The bicarbonate component was sufficient to change
urinary pH values, statistically significantly by Day 84, as
an indicator of acid base balance [21]. The blood bicar-
bonate as an indirect parameter was not different
between the groups. Other studies of mineral waters
containing bicarbonate at greater concentrations
(approximately 1 - 2 g/L) than employed here (650 mg/
L) have shown a decrease in bone resorption markers in
young women [22,23] and a lowering of markers of
atherosclerosis in postmenopausal women [24,25]. It is
likely that the level of 650 mg/L bicarbonate in the pre-
sent study was too low to elicit an effect on bone meta-
bolic and cardiovascular parameters over a short period.
In addition, the consumption of a high calcium mineral
water has shown that bone modelling parameters were
only affected when the study population had low dietary
mineral intakes [26].
The present study showed that consumption of mag-
nesium in alkaline aqueous formulation (magnesium
bicarbonate supplemented spring water) provided a
source of orally available magnesium as evidenced by
the increase in serum magnesium concentrations over
the 12 weeks of the study period. Other metabolic stu-
dies have shown that magnesium mineral waters with
magnesium content (110 mg/L and 282 mg/L) similar to
this study water of 120 mg/L could be easily absorbed
and retained in healthy men and women [27,28]. It has
been suggested that absorption becomes impaired with
increasing age [29], thus the magnesium bicarbonate
supplemented spring water could provide a source of
magnesium particularly in older women. However, since
this study did not measure dietary magnesium intake or
excreted magnesium, the absolute contribution of the
Table 5 Serum electrolytes over the study period for spring water and magnesium bicarbonate (supplemented) spring
water groups
Spring Water (n = 33) Supplemented Spring Water (n = 34)
Visit Day 0 Day 84 Day 0 Day 84
Bicarbonate (mmol/L) Mean (SD) 27.6 (1.84) 27.6 (1.60) 27.9 (1.94) 27.8 (1.93)
Change from baseline (Day 0) (SD) 0.0 (2.01) -0.1 (1.60)
*P value 0.511 0.790
Corrected Calcium (mmol/L) Mean (SD) 2.31(0.07) 2.29 (0.09) 2.32 (0.08) 2.31 (0.091)
Change from baseline (Day 0) (SD) -0.03 (0.07) -0.004 (0.06)
*P value 0.778 0.1504
Magnesium (mmol/L) Mean (SD) 0.86 (0.06) 0.86 (0.06) 0.87 (0.05) 0.90 (0.052)
Change from baseline (Day 0) (SD) 0.006 (0.04) 0.03 (0.03)
*P value 0.320 0.006
*p-value comparing groups at Day 0 (italics) and for change from Day 0 to Day 84
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Figure 1 Change in serum Parathyroid Hormone (PTH) levels in
the Magnesium supplemented Bicarbonate spring water and
spring water (control) groups at Day 14, 42 and 84. Values are
mean ± standard error by treatment group and study day
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Figure 2 Change in serum Magnesium in the Magnesium
Bicarbonate supplemented spring water and spring water
(control) groups at Day 14, 42 and 84. Values are mean ±
standard error by treatment group and study day
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remains unknown.
It is acknowledged that other parameters measured in
this study will be influenced by the composition of diet
and energy loads. Accordingly the rise in serum potas-
sium by Day 84 with the consumption of the supple-
mented water remains observational. Thus, despite the
requested maintenance of usual dietary habits by all
subjects in the study, the lack of dietary records in the
study population is a limitation of this exploratory
investigation.
In this present study, PTH concentrations remained
stable over 12 weeks in the magnesium bicarbonate
water group. This finding is consistent with other studies
in normal subjects where intake of oral alkaline [28] and
m a g n e s i u m[ 3 0 ]l o a d sd on o ta l t e rP T Hl e v e l si nt h e
short term. It remains to be determined, if the trend to
increase in PTH with the consumption of spring water
alone becomes sufficient to potentiate the action of PTH
on bone metabolism in a clinically meaningful way and if
magnesium bicarbonate supplemented spring water has
favourable effects on PTH concentrations and bone
metabolism with longer-term consumption.
In summary, these results suggest that the consump-
tion of magnesium rich bicarbonate spring water may
provide a source of magnesium to contribute to total
magnesium intake. Changes in urinary pH may, in the
longer term, lead to improved acid base balance. Longer
term studies, that include assessment of diet, urinary
volume and mineral excretion, are required to deter-
mine the clinical relevance of these findings.
Conclusions
Short term consumption of magnesium bicarbonate sup-
plemented spring water increased serum magnesium
and urinary pH in postmenopausal women. There was
no effect on bone metabolism or cardiovascular risk fac-
tors. Whether the former changes are of clinical rele-
vance with respect to various processes, such as those
associated with aging which have been linked to magne-
sium insufficiency and/or acidosis, remains to be deter-
mined by further research.
Additional material
Additional file 1: Analysis of *Spring Water (control). *spring (Peats
Ridge) water is commercially registered by the NSW government.
Additional file 2: Serum bone metabolic markers at all visits for two
water treatment groups.
Additional file 3: Serum lipid profile at all visits for two water
treatment groups.
Additional file 4: Blood pressure (BP) and pH at all visits for two
water treatment groups.
Additional file 5: Serum biochemistry at all visits for two water
treatment groups.
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